1. No category

===日本臨床検査医学会
機関誌==============================================================
Vol. 61
No. 7
2013
■原著
合成基質法とトロンビン生成試験による
各種ヘパリン類の抗 Xa 活性の評価 ····································································鈴
木
明
子・・・ 567
APTT 検査における検査試薬による実測値の違い ···············································田
中
紀
子・・・ 576
司会のことば··············································································································安
東
由喜雄・・・ 583
日本糖尿病学会における HbA1c 国際標準化の展開 ·············································柏
木
厚
HbA1c の国際標準化の課題と日本における対応 ··················································雨
宮
伸・・・ 594
臨床検査現場における NGSP 値導入とその後 ······················································石
橋
みどり・・・ 602
健診における HbA1c 結果表記の対応について ·····················································青
木
芳
和・・・ 607
HbA1c 測定における IFCC 値、NGSP 値、JDS 値の関係【抄録】 ····················梅 本
雅
夫・・・ 612
■第 59 回学術集会
シンポジウム 3：HbA1cの国際標準化とその波紋
典・・・ 585
International standardisation of Haemoglobin A1c based on
a metrologically sound international reference procedure【抄録】 ························ W. Garry John・・・ 613
シンポジウム 15：腎機能検査，尿検査の臨床的意義と今後の展開
司会のことば··············································································································宿
谷
賢 一・・・ 614
尾
勝・・・ 616
野
友 二・・・ 622
田
恒
腎機能評価法と CKD 重症度分類の新たな展開
～CKD 診療ガイド 2012 も含めて～···································································堀
尿検査を見直す－今，尿検査に診療が求めるもの，
これから尿検査が提供すべきもの－ ··································································油
蛋白尿／腎機能の臨床における意義
高畠研究(住民コホート)を中心に ······································································今
夫・・・ 629
保険収載された新規バイオマーカー
尿中 L-FABP の臨床的有用性··············································································池森(上條)敦子・・・ 635
■日本臨床検査医学会ニュース
日本臨床検査医学会 2013 年度 第 1 回臨床検査専門医・管理医審議会 たより ······························ 641
===The Official Journal of Japanese Society of Laboratory Medicine=======================
Rinsho Byori
Vol. 61
No. 7
2013
■Original
Assessment of Anti-Factor Xa Activity for Heparin and Related Products by
Chromogenic Assays and Thrombin Generation Tests··········································· Akiko SUZUKI・・・ 567
Comparison of Heparin-Induced Prolongation of APTT
in 12 Different Laboratories in Kyushu Area·························································Noriko TANAKA・・・ 576
■The 59th National Congress
Symposium 3：
Chairmen’s Introductory Remarks····················································································Yukio ANDO・・・ 583
Development of the HbA1c International Standardization of HbA1c
Measurement in Japan Diabetes Society······················································ Atsunori KASHIWAGI・・・ 585
The Worldwide Standardization of Hemoglobin A1c Measurement: The Current Statement
from the Japan Diabetes Society and the Issues to Be Solved····························Shin AMEMIYA・・・ 594
Introduction of the NGSP Value in Clinical Practice and Later ··························· Midori ISHIBASHI・・・ 602
Approach to the Changes of HbA1c Notation in Health Checkups···························Yoshikazu AOKI・・・ 607
Abstract·························································································································································· 612
Abstract·························································································································································· 613
Symposium 15：
Chairmen’s Introductory Remarks········································································ Kenichi SHUKUYA・・・ 614
Development of Evaluation of Kidney Function and Classification of Chronic Kidney Disease(CKD)
－Including CKD Clinical Practice Guide 2012－ ·················································Masaru HORIO・・・ 616
A Review of Urinary Examination－What Medical Practice Expects Now and
What Urinary Examinations Have to Provide in the Future－ ······························· Tomoji YUNO・・・ 622
Clinical Significance of Proteinuria and Renal Function:
Findings from a Population-Based Cohort, the Takahata Study····························· Tsuneo KONTA・・・ 629
Urinary L-Type Fatty Acid Binding Protein(L-FABP) as a New Urinary Biomarker
Promulgated by the Ministry of Health,
Labour and Welfare in Japan ································································ Atsuko KAMIJO-IKEMORI・・・ 635
■News
JSLM NEWS ·················································································································································· 641